Originally identified in human plasma, GHK-Cu has been shown to regulate over 4,000 genes involved in tissue regeneration, wound healing, and inflammation control (Pickart et al., 2012)
Most clinical data suggests tirzepatide lowers blood pressure in patients with existing hypertension, often through a combination of weight loss and GLP-1 receptor effects on blood vessel function
Similarly, TZP was avoided in patients with gallstone disease
Most patients feel benefits within one hour of administering a single spray of pure GSH into each nostril
Our team at Southeast Sculpting + Rejuvenation will help you every step of the way
Most clinicians suggest waiting at least one to two weeks after the last tirzepatide dose before starting a different GLP-1 agonist to minimize overlap and the risk of compounded side effects